US Patent Issued to Miotox on Jan. 27 for "Zonal and targeted methods and uses for treating a chronic post-traumatic headache associated with a post-traumatic stress disorder" (California Inventor)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,400, issued on Jan. 27, was assigned to Miotox LLC (Beverly Hills, Calif.).

"Zonal and targeted methods and uses for treating a chronic post-traumatic headache associated with a post-traumatic stress disorder" was invented by William J. Binder (Beverly Hills, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present specification discloses methods for treating a PTSD. The methods comprise extramuscularly administering a Botulinum toxin to an individual in one or more areas of a fronto-fascial layer located in a frontal head region, one or more areas of a temporoparietal-fascial layer located in a temporal head region, and one or more areas o...